Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/04/24
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 03/11/20
End: 02/15/23
Due: 02/15/24
Phase: N/A
Priority: Normal
Start: 10/18/23
End: 06/30/26
Due: 06/30/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of Sovilnesib in Subjects with Ovarian Cancer | NCT06084416 | Volastra Therapeutics, Inc. | user2@example.com | None | 2024-04-04 | 2025-07-31 | 2026-07-31 | - | - | 2025-07-14 |
| Study of AMG 650 in Adult Participants With Advanced Solid Tumors | NCT04293094 | Volastra Therapeutics, Inc. | user2@example.com | None | 2020-03-11 | 2023-02-15 | 2024-02-15 | - | - | 2025-07-14 |
| A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer | NCT05902988 | Volastra Therapeutics, Inc. | user2@example.com | None | 2023-10-18 | 2026-06-30 | 2027-06-30 | - | - | 2025-07-14 |